Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|March 21, 2019
Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision OncologyRoshni Ann Mathai, Ryali Valli Sri Vidya, B Shrikar Reddy, et al.
Pharmaceutics|January 28, 2026
Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine-Norfluoxetine Pharmacokinetics in Real-World Clinical ConditionsCarla González de la Cruz, Levin Thomas, Carmen Mata-Martín, et al.
F1000Research|December 30, 2025
Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular DrugsPrajakta Patil, Mrunal Desai, Gayathri Baburaj, et al.
European Journal of Clinical Pharmacology|August 12, 2024
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case seriesKeerthanaa B, Rashmi Appaji, Levin Thomas, et al.
Expert Review of Anti-Infective Therapy|May 24, 2022
Vitamin D receptor gene polymorphism and vitamin D supplementation on clinical/ treatment outcome in tuberculosis: current and future perspectivesSonal Sekhar Miraj, Navya Vyas, Shilia Jacob Kurian, et al.
European Journal of Clinical Pharmacology|July 19, 2022
Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic modelsLevin Thomas, Arun Prasath Raju, Chaithra, et al.
Expert Review of Clinical Pharmacology|January 30, 2024
Influence of N-acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patientsLevin Thomas, Arun Prasath Raju, S Chaithra, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Influence of CYP2D6, CYP2C19, and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish PatientsLevin Thomas, Carla González de la Cruz, Carmen Mata-Martín, et al.
Annals of Medicine|March 26, 2025
Pharmacogenomic heterogeneity of N-acetyltransferase 2: a comprehensive analysis of real world data in Indian tuberculosis patients and from literature and database reviewLevin Thomas, Chaithra, Yashi Batra, et al.
American Journal of Cancer Research|January 12, 2022
Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactionsMurali Munisamy, Nayonika Mukherjee, Levin Thomas, et al.
Pageof 3